Exane Derivatives’s Annaly Capital Management NLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-29
Closed -$593 731
2020
Q1
$593 Hold
29
﹤0.01% 580
2019
Q4
$1.13K Sell
29
-5,717
-99% -$208K ﹤0.01% 538
2019
Q3
$202K Sell
5,746
-4,500
-44% -$162K 0.04% 257
2019
Q2
$374K Buy
+10,246
New +$390K 0.07% 200
2019
Q1
Sell
-14,132
Closed -$555K 699
2018
Q4
$555K Hold
14,132
0.1% 167
2018
Q3
$578K Buy
14,132
+480
+4% +$20.1K 0.11% 151
2018
Q2
$567K Buy
13,652
+284
+2% +$11.8K 0.09% 169
2018
Q1
$551K Buy
13,368
+2,778
+26% +$118K 0.11% 159
2017
Q4
$504K Buy
10,590
+616
+6% +$29.2K 0.09% 163
2017
Q3
$486K Buy
9,974
+872
+10% +$42.7K 0.09% 137
2017
Q2
$439K Buy
9,102
+2,176
+31% +$103K 0.09% 145
2017
Q1
$308K Buy
+6,926
New +$295K 0.07% 162

Other funds holding NLY

Exane Derivatives's NLY Position: Q2 2020 in Review

Exane Derivatives sold out of Annaly Capital Management (NLY) in Q2 2020, closing a stake of 29 shares — an estimated $593 sold.

Exane Derivatives first reported a position in NLY in Q1 2017 and held it in 12 quarters. The position peaked at $578K in Q3 2018. 666 funds tracked by Wall St. Rank hold NLY as of Q2 2020.

  • Exane Derivatives reported no remaining Annaly Capital Management position as of Q2 2020 after selling out during the quarter.
  • Exane Derivatives sold 29 Annaly Capital Management shares in Q2 2020, an estimated $593.
  • Exane Derivatives first reported a position in Annaly Capital Management in Q1 2017 and held it in 12 quarters.
  • Exane Derivatives's Annaly Capital Management position peaked at $578K in Q3 2018.
  • 666 funds tracked by Wall St. Rank held Annaly Capital Management as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.